3,832 results on '"Cazzola, Mario"'
Search Results
2. Cardiovascular Events with the Use of Long-Acting Muscarinic Receptor Antagonists: An Analysis of the FAERS Database 2020–2023
3. Potential role of SIRT-1 and SIRT-3 as biomarkers for the diagnosis and prognosis of idiopathic pulmonary fibrosis
4. The effect of combining an inhaled corticosteroid and a long-acting muscarinic antagonist on human airway epithelial cells in vitro
5. Lung Microbiome as a Treatable Trait in Chronic Respiratory Disorders
6. Pharmacotherapies in Older Adults with COPD: Challenges and Opportunities
7. Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma?
8. Impact of biologics on lung hyperinflation in patients with severe asthma
9. Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD
10. Molecular taxonomy of myelodysplastic syndromes and its clinical implications
11. The novel inhaled dual PDE3 and PDE4 inhibitor ensifentrine for the treatment of COPD: A systematic review and meta-analysis protocol on trough FEV1 and exacerbation according to PRISMA statement
12. Is it preferable to administer a bronchodilator once- or twice-daily when treating COPD?
13. Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41
14. Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity
15. Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
16. Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms
17. Inhaled Corticosteroids in Adults with Non-cystic Fibrosis Bronchiectasis: From Bench to Bedside. A Narrative Review
18. Biological and immunosuppressive therapies for lung disease: a potential reciprocal influence between their use and malignancy
19. Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes
20. Are biologics effective on lung hyperinflation in patients with resistant asthma? A reply.
21. Clinically important deterioration: a composite tool for managing patients with COPD
22. TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups.
23. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
24. Developing a classification of hematologic neoplasms in the era of precision medicine
25. The 5T approach in asthma: Triple Therapy Targeting Treatable Traits
26. Patient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant HSPCs
27. Ineffective erythropoiesis and its treatment
28. Pseudouridine-modified tRNA fragments repress aberrant protein synthesis and predict leukaemic progression in myelodysplastic syndrome
29. Rationale and Clinical Use of Bronchodilators in Adults with Bronchiectasis
30. Sex differences in adult asthma and COPD therapy: a systematic review
31. Can FeNO be a biomarker in the post-COVID-19 patients monitoring?
32. The future of inhalation therapy in chronic obstructive pulmonary disease
33. Germ line DDX41 mutations define a unique subtype of myeloid neoplasms
34. Biologics for asthma and risk of pneumonia.
35. Doxofylline: Advancing and Empowering Equitable Asthma and COPD Management Beyond Tradition.
36. A clinician's guide to single vs multiple inhaler therapy for COPD.
37. Genomic Profiling for Predictive Treatment Strategies in Fibrotic Interstitial Lung Disease.
38. Bronchodilators for Airway Disease
39. Potential role of SIRT-1 and SIRT-3 as biomarkers for the diagnosis and prognosis of idiopathic pulmonary fibrosis
40. The pharmacological management of asthma in adults: 2023 update
41. The Impact of Thermal Water in Asthma and COPD: A Systematic Review According to the PRISMA Statement
42. Impact of long-acting muscarinic antagonists on small airways in asthma and COPD: A systematic review
43. SMART for the treatment of asthma: A network meta-analysis of real-world evidence
44. Exercise-Induced Asthma: Managing Respiratory Issues in Athletes
45. Controversy surrounding the Sputnik V vaccine
46. Use of Thiols in the Treatment of COVID-19: Current Evidence
47. Preexisting cardiorespiratory comorbidity does not preclude the success of multidisciplinary rehabilitation in post-COVID-19 patients
48. Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2P95-mutated neoplasms
49. Response to “The WHO classification of haematolymphoid tumours” (Editorial)
50. Bronchodilator reversibility testing in post-COVID-19 patients undergoing pulmonary rehabilitation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.